Pentraxin-3 in COPD: innocent bystander or amplifier?
Author:
- 31 March 2012
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 39 (4) , 795-796
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Pentraxin-3 Is a Novel Biomarker of Lung CarcinomaClinical Cancer Research, 2011
- Pentraxin 3—a marker of diastolic dysfunction and HF?Nature Reviews Cardiology, 2011
- PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patientsGenes & Immunity, 2010
- Regulation of leukocyte recruitment by the long pentraxin PTX3Nature Immunology, 2010
- An Integrated View of Humoral Innate Immunity: Pentraxins as a ParadigmAnnual Review of Immunology, 2010
- Genetic Variation in Pentraxin (PTX) 3 Gene Associates with PTX3 Production and Fertility in Women1Biology of Reproduction, 2010
- Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity*Critical Care Medicine, 2008
- Cancer-related inflammationNature, 2008
- Pentraxins in Innate Immunity: From C-Reactive Protein to the Long Pentraxin PTX3Journal of Clinical Immunology, 2007
- DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West AfricansGenes & Immunity, 2007